Molecular characterization of HER2-positive (HER2+) metastatic gastric and gastro-esophageal junction cancer patients (mGC): Identification of resistance mechanisms to trastuzumab-based therapy (TTZ)

  1. Alsina, M.
  2. Hierro, C.
  3. Sastre, J.
  4. Guardeño, R.
  5. Lopez, C.
  6. Pineda, E.
  7. Aranda, E.
  8. Manzano, J.L.
  9. Galán, M.
  10. Longo, F.
  11. Visa, L.
  12. Landolfi, S.
  13. Jimenez, J.
  14. Sperinde, J.
  15. Pandiella, A.
  16. Tabernero, J.
  17. Hernandez-Losa, J.
  18. Arribas, J.
  19. Scaltriti, M.
  20. Nuciforo, P.
Zeitschrift:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Datum der Publikation: 2016

Ausgabe: 27

Seiten: vi213

Art: Artikel

DOI: 10.1093/ANNONC/MDW371.21 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus